The National Institutes of Health launched a study to determine how many adults in the U.S. without a confirmed COVID-19 history have antibodies to the virus. By collecting blood samples from volunteers, researchers hope to model the degree to which the virus spread undetected in the U.S. “These crucial data will help us measure the impact of our public health efforts now and guide our COVID-19 response moving forward,” said Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases.

Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…